No quarterly revenue total was found in CTT PHARMACEUTICAL HOLDINGS, INC.'s SEC filings.
CTT Pharmaceutical Holdings, Inc. (CTTH) files with the SEC under industry code 2834, Pharmaceutical Preparations.
Revenue
—
Net income
$-99,908
+70.8% vs prior quarter
Operating cash flow
$-26,129
-68.3% vs prior quarter
Free cash flow
—
EPS
$0.00
Dividend per share
None
Shares outstanding
59.72M
+179.7% vs prior quarter
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CTTH (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Tampa, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1035422
- Former names
- Mindesta Inc. (until Jul 21, 2015); INDUSTRIAL MINERALS INC (until Jul 18, 2011); PNW CAPITAL INC (until May 21, 2002); WINCHESTER MINING CORP (until May 26, 2000)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 YTD Jun 30, 2026 |
Q3 FY2015 Sep 30, 2015 |
Q2 FY2015 Jun 30, 2015 |
Q1 FY2015 Mar 31, 2015 |
Q4 FY2014 Dec 31, 2014 |
|---|---|---|---|---|---|
| Operating income | — | — | — | -$337,052 | — |
| Net income | -$99,908 | -$341,930 | -$362,657 | -$337,052 | -$628,519 |
| Operating cash flow | -$26,129 | -$15,527 | -$29,158 | -$39,652 | -$46,837 |
| Total assets | $67,434 | $922,038 | $1.2M | $1.4M | $1.7M |
| Total liabilities | — | $183,960 | $156,373 | $211,696 | $169,490 |
| Stockholders' equity | $26,043 | $738,078 | $1.0M | $1.2M | $1.5M |
| Cash and investments | $31 | $32,121 | $46,073 | $73,447 | $81,179 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 30, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Auditor change
|
Oct 9, 2026 | Oct 8, 2026 |
| 8-K |
Current report
Auditor change
|
Oct 7, 2026 | Oct 2, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 23, 2026 | Aug 10, 2026 |
| 10-Q | Quarterly report | Sep 17, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Other events
|
Aug 12, 2026 | Aug 11, 2026 |
All 416 CTT Pharmaceutical Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.